Aberrant glycosylation of L-selectin on the lymphocytes of chronic leukemiaPRYSTAS, E. M; PARKER, C. J; HOLGUIN, M. H et al.Leukemia. 1993, Vol 7, Num 9, pp 1355-1362, issn 0887-6924Article

Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factorHOLGUIN, M. H; MARTIN, C. B; BERNSHAW, N. J et al.The Journal of immunology (1950). 1992, Vol 148, Num 2, pp 498-502, issn 0022-1767Article

Membrane inhibitor of reactive lysisHOLGUIN, M. H; PARKER, C. J.Current Topics in Microbiology and Immunology. 1992, Vol 178, pp 61-85, issn 0070-217XArticle

Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase IIα messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantroneGRAYDON HARKER, W; LYNN SLADE, D; PARR, R. L et al.Cancer research (Baltimore). 1995, Vol 55, Num 21, pp 4962-4971, issn 0008-5472Article

Enhanced expression of the complement regulatory protein, membrane inhibitor of reactive lysis (CD59), is regulated at the level of transcriptionHOLGUIN, M. H; MARTIN, C. B; WEIS, J. H et al.Blood. 1993, Vol 82, Num 3, pp 968-977, issn 0006-4971Article

Alterations in the topoisomerase IIα gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase IIβ enzyme in a mitoxantrone-resistant HL-60 human leukemia cell lineHARKER, W. G; SLADE, D. L; PARR, R. L et al.Cancer research (Baltimore). 1995, Vol 55, Num 8, pp 1707-1716, issn 0008-5472Article

Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuriaHOLGUIN, M. H; WILCOX, L. A; BERNSHAW, N. J et al.The Journal of clinical investigation. 1989, Vol 84, Num 5, pp 1387-1394, issn 0021-9738, 8 p.Article